Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Morgan Stanley’s disclosures are a treasure trove of information on everything from trading Value-at-Risk to the health of its $4T wealth-management franchise. But finding those details inside a 300-page report is tedious. This page curates every filing the firm submits to EDGAR, then layers Stock Titan’s AI so Morgan Stanley SEC filings are explained simply.
Need the latest Morgan Stanley quarterly earnings report 10-Q filing or an Morgan Stanley 8-K material events explained summary? We post them in real time and generate concise AI-powered breakdowns of segment revenue, capital ratios, and liquidity buffers. Curious about management’s trading activity? Our alerts track Morgan Stanley insider trading Form 4 transactions and show Morgan Stanley Form 4 insider transactions real-time, highlighting patterns before they hit the news. When proxy season arrives, the platform pinpoints pay packages inside the Morgan Stanley proxy statement executive compensation section—no more hunting through exhibits.
Professionals use these tools to:
- Compare quarter-over-quarter margins with a click using our Morgan Stanley earnings report filing analysis
- Monitor Morgan Stanley executive stock transactions Form 4 for buy-sell trends
- Read a Morgan Stanley annual report 10-K simplified summary that clarifies risk factors, legal reserves, and capital plans
- Ask natural questions like “understanding Morgan Stanley SEC documents with AI” and receive instant answers
Whether you’re gauging deal pipelines, stress-testing balance sheets, or assessing leadership’s confidence, our AI-powered summaries, expert context, and real-time updates turn raw filings into actionable knowledge—faster than opening a PDF.
Offering overview. Morgan Stanley Finance LLC, guaranteed by Morgan Stanley (NYSE: MS), is marketing “Worst-of SPX and RTY Trigger PLUS” notes maturing on August 3 2028. The $1,000-denominated securities deliver 142%-152% leveraged upside linked to the worst performer of the S&P 500® (SPX) and Russell 2000® (RTY) indices.
Key terms.
- Leverage factor: 142%–152% on any positive index return.
- Downside threshold: 75% of the initial level (25% buffer).
- Pricing date: July 31 2025; Observation date: July 31 2028; Maturity: Aug 3 2028.
- Estimated value: $963.30 versus the $1,000 issue price (reflects structuring & hedging costs).
- No coupons; securities will not be listed; full credit exposure to Morgan Stanley.
Payoff mechanics. At maturity investors receive: (i) principal plus 1.42-1.52× any positive move in the worst index; (ii) full principal if the worst index has not fallen more than 25%; (iii) a dollar-for-dollar loss if the worst index closes below 75% of its start level—potentially down to zero.
Risk highlights. Investors are exposed to (1) market risk on two equity indices, including small-cap volatility, (2) issuer/guarantor credit risk, (3) liquidity risk because the notes are unlisted, (4) valuation starting below par, and (5) uncertain U.S. tax treatment.
Bottom line. The notes suit investors with a moderately bullish 3-year view on U.S. equities who can absorb potential principal loss and illiquidity in exchange for enhanced upside and a 25% buffer.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is marketing Buffered Jump Securities with an Auto-Callable feature linked to the worst performer among the S&P 500 (SPX), Nasdaq-100 (NDX) and Russell 2000 (RTY) indexes. Each $1,000 security can be automatically redeemed on 5 Aug 2026 if all three indexes are at or above their initial levels; investors would then receive an early redemption payment of $1,130–$1,150, capping upside thereafter.
If the note is not called, investors participate in 150% of any positive performance of the worst-performing index at maturity on 3 Aug 2028. Downside is mitigated by a 20% buffer; losses begin only if the worst performer has declined by more than 20%, after which the payoff falls one-for-one, exposing investors to a maximum 80% loss.
The issuer’s estimated value is $964.80 (≈3.5% below issue price), reflecting fees and hedging costs. The notes pay no periodic interest, will not be listed, and expose holders to Morgan Stanley’s credit risk. Key risk factors include limited liquidity, valuation opacity, early-call uncertainty, and tax complexity.